INTRODUCTION
Alopecia areata (AA) is a T cell-mediated autoimmune disease that targets hair follicles. Collapsed immune privilege in hair follicles may play a crucial part in the pathogenesis of AA 1 . Interferon (IFN)-γ secretion is triggered by infection, bacterial superantigens, psycho-emotional stressors, skin microtrauma, or other damage to hair follicles and collapse of the immune privileged state, which is maintained by α-melanocyte-stimulating hormone (α-MSH), transforming growth factor (TGF)-β1 and insulin-like growth factor-I that upregulates major histocompatibility complex (MHC) class I expression in hair follicles. Be-cause MHC class I molecules are strongly expressed in AA lesions, CD8 + T cells react to autoantigens in the hair follicles 2 . In the event that a given individual has pre-existing autoreactive CD8 + T cells, which must receive appropriate co-stimulatory signals and receive help from CD4 + T cells, a cytotoxic T cell attack is launched on the hair matrix. This attack activates a vicious circle of secondary, follicle-damaging autoimmune phenomena, whose quality and magnitude largely determine the degree of resulting hair follicle damage (dystrophy) and thus the clinical manifestations and progression of AA. Some authors have recently proposed that AA may be associated with Th17 cells, in addition to Th1 cells. However, their contributory roles in AA pathogenesis have not been elucidated to date 3 . Tanemura et al. 4 demonstrated infiltration of CD4 + interleukin (IL)-17A+Th17 cells in the dermis, particularly around the hair follicles in patients with AA. Lew et al. 5 showed that an IL17RA gene polymorphism might contribute to increased susceptibility to AA in the Korean population, and that the IL17RA gene polymorphism may be associated with age of AA onset. Although the bulge region is not affected by an autoimmune response in AA because of 'non-scarring' alopecia 4 , T lymphocytes sometimes infiltrate into the bulge region as well as the intra-and peri-bulbar areas 6, 7 . Inflammatory injury involves the bulbar region of hair follicles and spares the bulge region in early AA lesions, but it does not lead to permanent hair loss 8 . However, a few patients with AA may lose their ability to grow new hair, and the involvement of stem cells has been suggested in this type of 'non-scarring' alopecia 9 .
Recently, several biomarkers of human bulge cells, including keratin15 (K15), follistatin, and CD200, have been identified. In addition, stem cell involvement was demonstrated in two elderly women with AA and unusual lymphocytic cell infiltrates surrounding both the bulge and the bulbar regions. Both K15 and CD200 immunoreactivities were decreased in the affected bulge lesions of bulge-involving AA, compared to that of the bulge lesions of common AA cases 10 .
In this study, we identified the contributory roles of various effector T cell subsets, including Th17 cells, Th1 cells, and CD8 + cytotoxic T cells, along with their related cytokines, in the immunopathogenesis of AA.
MATERIALS AND METHODS
Association of histopathological grades with various clinical prognostic factors and therapeutic outcomes , and AA universal is type (hair loss over the whole body). We treated the patients with topical immunotherapy using diphenylcyclopropenone, topical application of cyclosporine (20 mM), triamcinolone acetonide intralesional injections, topical application of corticosteroid, and oral administration of cyclosporine. Therapeutic outcomes were categorized into 6 grades, A5 (100% regrowth), A4 (75%∼99% regrowth), A3 (50%∼75% regrowth), A2 (25%∼50% regrowth), A1 (＜25% regrowth), and A0 (no change or progression), by the extent of hair regrowth and degree of reduction in hairless patches.
2) Histopathological grading
Histopathological features of hairless patches in patients with AA were categorized into four grades according to the Uno and Orecchia classification scheme. Type 1 was defined as "microfollicles with severe associated changes such as hair disruption, follicular degeneration, and perifollicular inflammation"; type 2 as "microfollicles or medium follicles with severe associated changes"; type 3 as "medium follicles with moderate associated changes such as proliferation of perifollicular fibrous tissue"; and type 4 as "large follicles without any associated changes."
Expression of effector T cells and cytokines in patients AA
We conducted immunohistochemistry for CD4, CD8, IFN-γ, TGF-β1, and TGF-β2, and double immunofluorescence for CCR6/CCL20 and CCR6/CCR5 in three patients for each group, types 1, 2, 3, and 4 by the Uno and Orecchia classification. We observed and photographed these sections through light microscopy and immunofluorescence microscopy.
1) Immunohistochemistry for CD4, CD8, IFN-γ, TGF-β1, and TGF-β2 in the bulge region and/or in the intra-and peri-bulbar areas
Paraffin blocks for the biopsied specimens from the hairless patches of 9 patients with AA (type 1, n=3; type 2, n=3; type 3, n=3; and type 4, n=0) were cut into 4-μm thick sections and incubated at 58 o C overnight. The paraffin sections were deparaffinized with 100% xylene two times for 10 minutes each and washed with graded concentrations (100%, 90%, 70% and 50%) of ethyl alcohol, followed by application of 0.3% phosphate buffered saline with tween 20 (PBST) solution for 10 minutes and a wash in PBS solution. We rewarmed the sections using 750-watt microwave in 10 mM citrate buffer (pH 6.0) for 5 minutes, followed by warming slides two times for 5 minutes each to retrieve antigens. We cooled sections at room temperature for 20 minutes, and subsequently washed sections using washing buffer solution and blocked endogenous peroxidase with 0.3% H2O2 for10 minutes. The sections were then washed with washing buffer three times and reacted at 45 o C for 10 minutes with non-immune goat serum to remove binding of non-specific proteins. The following primary antibodies were used: monoclonal mouse anti-human CD4 (NCL-CD4-1F6; Novocastra Laboratories Ltd., Newcastle Upon Tyne, UK), monoclonal mouse antihuman CD8 (NCL-CD8-4B11; Novocastra Laboratories Ltd.), rabbit anti-IFN-γ antibody (sc-8308; Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), mouse monoclonal anti-TGF-β1 antibody (sc-52893; Santa Cruz Biotechnology Inc.). The sections were reacted with the antibodies at room temperature for 30 minutes. After washing with buffer solution three times, the sections were reacted with secondary antibody (horse radish peroxidase, DAKO Envision Detection kit mouse/rabbit) at room temperature for 30 minutes. After washing with buffer solution, the sections were incubated with 0.025% diaminobenzidine (DAB) solution for a chromogen reaction. Counterstaining was performed with Mayer's hematoxylin, and the slides were observed by optical microscope and photographed.
2) Double immune fluorescence detection of CCR6/ CCL20 and CCR6/CCR5 respectively. The ages of onset ranged from 1 year to 76 years, and the ages of onset according to histopathological grade were 29.9, 34.4, and 35.8 years in types 1, 2, and 3, respectively. Hence, the histopathological grades showed an inverse correlation with age of onset (p=0.027; Table  1 ). The duration of disease was 25.1 months on average, and the durations of disease according to histopathological grade were 29.5, 23.1, and 21.4 in types 1, 2, and 3, respectively. Hence, the histopathological grades showed a positive correlation with age of onset (p=0.002; Table  1 ). We categorized the extent of hair loss as S1∼S5 (extent of hair loss, S1: ＜5%, S2: 5%∼25%, S3: 25%∼50%, S4: 50%∼75%, S5: ≥75%). The type 1 group showed the highest grade of hair loss (23.6% of patients were classified as S5), and the Type 3 group showed the lowest grade (13.2% of patients were classified as S5). The extent of hair loss showed a positive correlation with histopathological grade (p＜0.001; Table 1 ). Therapeutic outcomes were 57.1%, 69.1% and 78.2% in types 1, 2, and 3, Values are presented as mean±standard deviation or number (%). The severe histopathologic gradings were significantly associated with early age of onset, longer disease duration, greater extent hair loss (extent of hair loss; S1: ＜5%, S2: 5%∼25%, S3: 25%∼50%, S4: 50%∼75%, S5: ≥75%), poorer response to treatment (extent of hair regrowth; A5: 100%, A4: 75%∼99%, A3: 50%∼75%, A3: 25%∼50%, A1: ＜25%, A0: no change or progression).
respectively. Histopathological grades showed a negative correlation with therapeutic outcomes (p=0.020; Fig. 1 ). Moreover, we observed, especially at the hair bulge (Bg) region, that CD4 + and CD8 + T lymphocytes showed greater infiltration with histopathological grades associated with more severe disease (Fig. 2) . By double immunofluorescence, CCR6 + lymphocytes infiltrated the intra-or peri-bulbar areas (Bb) in a denser pattern with greater histopathology (Fig. 3) , and CCL20 was expressed in epithelial cells of the hair bulb. CCR5 + lymphocytes also infiltrated at intra-or peri-bulbar areas (Bb) in a denser pattern with greater histopathology (Fig. 4) . More specifically, CCR6 + lymphocytes also infiltrated at the bulge region (Bg), and with greater histopathology showed denser infiltration of CCR6 + lymphocytes (Fig. 5) .
2) Expression of IFN-γ, TGF-β1, and TGF-β2 in AA sections IFN-γ + cells infiltrated the dermis around the hair bulb and the more severe disease groups by histopathological grade showed denser expression of IFN-γ (Fig. 6 ). TGF-β 1 was expressed in the epithelia of the outer root sheath, regressive epithelial strand, fibrous dermal sheath, and dermal sheath cells induced by inflammatory changes. The more severe disease group by histopathological grade also showed denser expression of TGFβ-1 (Fig. 7) . Interestingly, TGF-β2 was expressed primarily in the dermal papilla area, and the more severe disease group by histopathological grade showed less expression of TGF-β 2 as the size of the dermal papilla area decreased (Fig. 8) .
DISCUSSION
In the present study, as reported elsewhere regarding clinical prognostic factors in AA, earlier onset of age (p=0.019), longer duration of disease (p=0.018), greater extent of hair loss (p＜0.001), and poorer therapeutic outcomes (p＜0.001) were significantly correlated with greater histo- Although it is widely known that the bulge area is not affected by an autoimmune response in AA 4 , some authors recently reported that T cells could infiltrate the bulge region 6, 7 . We demonstrated also in this study that the denser T cell (CD4 + T and CD8 + T cells) infiltrates at the bulge region were associated with greater histopathology 11 , and that denser CCR6 + putative Th17 cells infiltrated the hair bulge region primarily in the histopathological grades associated with more severe disease in AA hair follicles ( to grow new hairs, and growth of hair in the follicle is interrupted during chronic AA pathogenesis, resulting in greater histopathology. Recently, a study of the pathogenic role of Th17 cells focused on autoimmune inflammatory diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis 12 . AA is characterized by a Th1 response, although the involvement of Th17 has not been elucidated 13 . CD8 + T cells are considered the direct modulators of hair loss, whereas CD4 + CD25 -T cells play a classic helper role in AA onset. Th17 cells are involved in the promotion of autoimmunity, and Treg cells are involved in the control of Th17 cells. Consequently, the balance of Th17/Treg cells is believed to be important in the control of immunity mediated by Th17 cells 11 . Recently, Th17 cells and Th1 cells were proposed to be associated with AA pathogenesis 4 . In this study, we found that Th17 cells as well as AA via Th1 immunity; it is released by T cells and antigen presenting cells that infiltrate the hair bulbs and bulges 14 .
After autoantigens such as MHC molecules are expressed under the influence of IFN-γ, immune privilege collapses and hair growth is interrupted [15] [16] [17] . In previous studies, high serum IFN-γ levels correlated with more severe clinical features. Therefore, IFN-γ can serve as a prognostic factor that reflects the inflammatory state of AA 18, 19 . In contrast, the correlation between in situ IFN-γ expression in AA lesions with the histopathological grades has not been determined. In this study, we showed that IFN-γ + cells were expressed with histopathological grades associated with more severe disease. In the process of AA generation, targeted cell killing by CD8 + cytotoxic T cells with the help of CD4 + T helper cells reflects mainly a Th1-mediated immune response, which is usually dependent on the production of IFN-γ 20 .
Potent immunosuppressants such as TGF-β1 and α-MSH are prominently expressed in the proximal anagen hair follicle 21 . TGF-β1 is considered an immunosuppressant that helps maintain immune privilege by inhibiting expression of autoantigens in the follicular epithelia. TGF-β1 is expressed in the hair bulb in the early anagen period and in the outer root sheath and degenerative epithelial strand in the transition period (anagen to telogen), and inhibits follicular epithelial proliferation, resulting in apoptosis and telogen induction 22, 23 . In this study, TGF-β1 was expressed in the outer root sheath and degenerative epi- thelial strand in the transition period and also in the fibrous dermal sheath and dermal sheath cells with inflammation. These results suggest that TGF-β1 has an important role in AA pathogenesis in inducing catagen hair and perifollicular fibrosis by modifying the extracellular matrix. In the normal hair cycle, TGF-β2 is also expressed in the follicular outer root sheath in the anagen period. TGF-β2 is expressed in the hair matrix and degenerating follicular strands in the transition period. In the presence of neutralizing antibody, as well as a TGF-β antagonist, hair follicles were markedly elongated in a concentration-dependent manner. Elongation of the hair follicle was significantly suppressed by TGF-β2. These results strongly suggest that TGF-β2 plays an essential part in the induction of the catagen phase of the human hair cycle 24 . However, in contrast to results from previous studies, TGF-β2 was not found to be expressed on the degenerative follicular epithelia in this study. Interestingly, TGF-β2 may also play an important role in the genesis of hair follicles because it is expressed on the hair papilla 25 . The dermal papilla is the most important mesenchymal component in hair follicle formation, and it has an essential role in follicular proliferation through its interaction with the epithelia of hair matrix (mesenchymal epithelial interaction). In our study, TGF-β2 was expressed in the dermal papilla area, and its expression was inversely correlated with the histopathological grade and with size of the dermal papilla area.
In conclusion, we identified the role of effector T cell subsets and cytokines, including IFN-γ and TGF-β, in AA pathogenesis. As in previous studies, CD4 + T cells mainly infiltrated the peribulbar area in the dermis, whereas CD8 + T cells mainly infiltrated the intrabulbar area, and the denser T lymphocytes infiltrated with greater histopathology at hair bulbar area (Bb). Further, we also observed that T cells (CD4 + and CD8 + T cells) infiltrated the bulge region in the groups with histopathological grades associated with more severe disease. Therefore, we hypothesizes that severe hair loss in patients with chronic AA may result from the destruction of bulge stem cells in the bulge region as well as hair matrix stem cells in the bulb area. In addition, Th17 immunity plays an important role other than Th1 immunity in the development of AA. IFN-γ + cells infiltrated into the dermis around the hair bulb, and the histopathological grades associated with more severe disease showed more expression of IFN-γ as a putative prognostic factor. TGF-β2 was expressed primarily in the dermal papilla area and in histopathological grades associated with more severe disease, with the ex-pression of TGF-β2 inversely correlated with the size of dermal papilla area, reflecting interrupted folliculogenesis in an inflammatory condition such as AA.
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